Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 47, 6451-6458, December 15, 1987]
© 1987 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keski-Oja, J.
Right arrow Articles by Moses, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keski-Oja, J.
Right arrow Articles by Moses, H. L.

Immunodetection and Modulation of Cellular Growth with Antibodies against Native Transforming Growth Factor-ß1

Jorma Keski-Oja, Russette M. Lyons and Harold L. Moses2

Department of Cell Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232

In an attempt to identify and quantitate latent and active forms of transforming growth factor ß (TGFß) without the use of cell cultures and to test for autocrine stimulation by TGFß, rabbit antibodies were raised against native human and porcine platelet-derived TGFß. A radio-immunoassay for TGFß was developed using radioiodinated TGFß, anti-TGFß antibodies, and protein A. Inhibition in the radioimmunoassay was achieved with nanogram quantities of TGFß, comparable to the sensitivity of radioreceptor assays. Analyses of the TGFß levels of conditioned medium from cultured cells indicated that the latent form(s) of TGFß is not detectable in the radioimmunoassay established using antibodies raised against native TGFß. Immunoprecipitation analysis of radiolabeled conditioned medium revealed a specific Mr 25,000 band only after acidification. A Mr 62,000 protein was observed with and without prior acidification of the medium but could not be competed with unlabeled TGFß in the immunoprecipitation indicating antigenic unrelatedness. The anti-TGFß IgG inhibited the binding of [125I]TGFß to the cell surface receptors in a radioreceptor assay. TGFß inhibition of A549 cell growth was reversed by the antibodies, which also neutralized the growth inhibitory effects of TGFß on AKR-2B cells in a monolayer [3H]thymidine incorporation assay as demonstrated by prevention of TGFß inhibition of insulin and epidermal growth factor-stimulated DNA synthesis. The antibodies also effectively inhibited spontaneous soft agar growth of AKR-MCA fibroblasts, providing evidence for autocrine secretion of TGFß as a mechanism of their anchorage-independent growth.

1 Supported by Grant CA 42572 awarded by the National Cancer Institute, Department of Health and Human Services, and by a contract from R & D Systems, Minneapolis, MN.

2 To whom requests for reprints should be addressed.

Received 4/ 6/87. Revised 8/28/87. Accepted 9/ 8/87.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1987 by the American Association for Cancer Research.